Lung cancer physical examination
Jump to navigation
Jump to search
|
Lung cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lung cancer physical examination On the Web |
|
American Roentgen Ray Society Images of Lung cancer physical examination |
|
Risk calculators and risk factors for Lung cancer physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy M.D Dildar Hussain, MBBS [2]
Overview
Common physical examination findings of lung cancer include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea.
Physical Examination
Common physical examination findings of lung cancer include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea.[1][2][3][4][5][6][7]
Appearance of the Patient
Vital Signs
- Vital signs are generally within normal limit, but patients with severe disease may present with:
- Low-grade fever
- Decreased SPO2
- Tachypnea
- Tachycardia
- Hypotension
Skin
HEENT
Neck
- Neck examination of patients with lung cancer is usually normal.
Lungs
- Decreased/absent breath sounds
Heart
- Cardiovascular examination of patients with lung cancer is usually normal.
Abdomen
Back
- Back examination of patients with lung cancer is usually normal.
Genitourinary
- Genitourinary examination of patients with lung cancer is usually normal.
Neuromuscular
- Bone pain
- Fractures (usually in the vertebrae, femur, pelvic bones, and the ribs)
- Cranial nerve palsies
Extremities
- Clubbing of fingers
- Swelling of hands and feet
- Weakness
- Hemiplegia
- Shoulder pain (caused by a Pancoast tumor)
- Thinning arms and legs
References
- ↑ Degner, Lesley F.; Sloan, Jeffrey A. (1995). "Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer". Journal of Pain and Symptom Management. 10 (6): 423–431. doi:10.1016/0885-3924(95)00056-5. ISSN 0885-3924.
- ↑ Feinstein AR, Wells CK (1990). "A clinical-severity staging system for patients with lung cancer". Medicine (Baltimore). 69 (1): 1–33. PMID 2299974.
- ↑ Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J (1985). "Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont". Cancer. 56 (8): 2107–11. PMID 2992757.
- ↑ Hirshberg B, Biran I, Glazer M, Kramer MR (1997). "Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital". Chest. 112 (2): 440–4. PMID 9266882.
- ↑ Kuo CW, Chen YM, Chao JY, Tsai CM, Perng RP (2000). "Non-small cell lung cancer in very young and very old patients". Chest. 117 (2): 354–7. PMID 10669674.
- ↑ Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, Frese S, Schmücking M, Blumstein NM, Diehm N, Bals R, Hamacher J (2011). "Superior vena cava syndrome in thoracic malignancies". Respir Care. 56 (5): 653–66. doi:10.4187/respcare.00947. PMID 21276318.
- ↑ Buccheri, G. (2004). "Lung cancer: clinical presentation and specialist referral time". European Respiratory Journal. 24 (6): 898–904. doi:10.1183/09031936.04.00113603. ISSN 0903-1936.